Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Masumi Ueda
Concurrent Use of Blinatumomab and Donor Lymphocyte Infusion (DLI) for Treatment of Relapsed Precursor B Cell Acute Lymphoblastic Leukemia (Pre B ALL) After Allogeneic Hematopoietic Cell Transplant (HCT)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
CAR-T Cells and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Immunotherapy
Oncology
Allergy
Immunology
Survival Differences Between Adolescents/Young Adults and Children With B Precursor Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
TEL-AML1 Positivity in Relapsed B Cell Precursor Acute Lymphoblastic Leukemia in Childhood
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse
JAMA Oncology
Cancer Research
Oncology
Prophylaxis and Treatment of Acute Lymphoblastic Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation
OncoTargets and Therapy
Oncology
Pharmacology
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse After Transplant
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Pcn77 - Budget Impact Analysis of Blinatumomab for the Treatment of Pediatric Patients With Philadelphia Negative Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in Mexico
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation
Leukemia Research
Cancer Research
Oncology
Hematology
Treatment of Relapsed Acute Myeloid Leukemia With MLL/AF6 Fusion After Allogeneic Hematopoietic Stem Cell Transplantation With Gemtuzumab Ozogamicin With a Long Interval Followed by Donor Lymphocyte Infusion
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology